ArticleBMJ open2024

Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China.

Li Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.